Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

108.82 +6.95 (+6.82%)

Streaming Delayed Price Updated: 1:02 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

With Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble? ↗

May 22, 2021

Guardant Health released earnings earlier this month, disappointing investors with its sluggish revenue growth and increasing expenses.

Via The Motley Fool

Guardant360® CDx Receives FDA Approval as Companion Diagnostic for Janssen’s RYBREVANT™ (amivantamab-vmjw) for Use in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

May 21, 2021

From Guardant Health, Inc.

Via Business Wire

Why Exact Sciences Stock Soared Today ↗

May 20, 2021

The company's Cologuard DNA test appears to be in good shape to maintain its market leadership.

Via The Motley Fool

Guardant Had Colon Cancer Data, But Rival Exact Popped — Here's Why ↗

May 20, 2021

Guardant and Exact are in a "win-win situation," an analyst said Thursday as EXAS stock surged on a comparison to Guardant in colon cancer detection.

Via Investor's Business Daily

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Guardant Health to Participate in Upcoming June Investor Conferences

May 20, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers

May 19, 2021

From Guardant Health, Inc.

Via Business Wire

Exact Sciences' First-Quarter Results Show Its Strength Under Pressure ↗

May 15, 2021

Despite ongoing pandemic-related headwinds, the medical diagnostic test maker's revenue grew. So how will it perform as those headwinds dissipate?

Via The Motley Fool

3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗

May 13, 2021

Falling costs are ushering in a new era of screening for a dreaded disease.

Via The Motley Fool

What 7 Analyst Ratings Have To Say About Guardant Health ↗

May 07, 2021

Guardant Health (NASDAQ:GH) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1...

Via Benzinga

Guardant Health Inc (GH) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

GH earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 06, 2021

Gainers T2 Biosystems (NASDAQ:TTOO) share...

Via Benzinga

Guardant Health Reports First Quarter 2021 Financial Results

May 06, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health Appoints Craig Eagle, MD as Chief Medical Officer

May 03, 2021

From Guardant Health, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity

April 30, 2021

From Guardant Health

Via Business Wire

Guardant Health to Participate in the BofA Securities 2021 Healthcare Conference

April 29, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Collaboration With Daiichi Sankyo to Develop Guardant360® CDx as a Companion Diagnostic for Enhertu® in Advanced Metastatic Non-Small Cell Lung Cancer

April 27, 2021

From Guardant Health, Inc.

Via Business Wire

Disruptor Alert: These 2 Companies Are Changing Cancer Care ↗

April 24, 2021

Their liquid biopsies are giving doctors new and better tools to spot, track, and treat cancers.

Via The Motley Fool

Guardant Health to Report First Quarter Financial Results on May 6, 2021

April 12, 2021

From Guardant Health, Inc.

Via Business Wire

Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers

April 10, 2021

From Guardant Health, Inc.

Via Business Wire

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.